FASCINATION ABOUT MBO128

Emily Bodnar’s rating is based to the anticipation of significant milestones for Agenus in the coming 12 months, specially the potential filing of a Biologics License Application (BLA) for their lead drug candidate, botensilimab (bot). Agenus has dosed in excess of 900 clients with bot throughout many stable tumors, exhibiting a motivation to com